7th Annual ECD Medical Symposium Milan, Italy
Milan Medizinisches Symposium Group Picture 2019
Symposium Summary
Approximately 38 medical professionals from nine countries attended the Annual ECD Medizinisches Symposium in 2019. Twelve oral abstracts were presented, along with an additional four poster presentations. As an invited speaker, Prof. Luigi Naldini, delivered a talk titled “Genetic engineering of hematopoiesis to treat
inherited diseases and cancer.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.
Erfahrungen der Teilnehmer
“ECDGA provides important Ressourcen for my patients that has led to faster Diagnose. It also provides a community for patients with a rare disease to feel less alone.”
– Mark Heaney, MD, 2019 Attendee
Programs with Symposium Agenda
Presentations
| Moderator | Presentation Slides | English Video |
|---|---|---|
| Jithma P. Abeykoon, MD | Histopathologic Mimics of Erdheim-Chester Disease | Nein Videos available |
| Benjamin H. Durham | Novel Alterations in CSF1R, RET, and Other Diverse Kinases in the Histiocytoses with Biochemical and Structural Insights into Their Mechanisms of Activation | Nein Videos available |
| Marina Ferrarini, MD | Novel Alterations in CSF1R, RET, and Other Diverse Kinases in the Histiocytoses with Biochemical and Structural Insights into Their Mechanisms of Activation | Nein Videos available |
| Dr. med. Filip Janku, PhD | MEK inhibition with trametinib in patients with non-Langerhans cell histiocytosis irrespective of BRAF mutation status | Nein Videos available |
| Francesco Pegoraro, MD | Erdheim-Chester with multiple lesions related to BRAF V600E mutation. A simple coincidence? | Nein Videos available |
| Julien Haroche, MD, PhD | PD-1/PD-L1 expression is frequent and correlates with inflammation in Erdheim-Chester disease | Nein Videos available |
| Rikhia Chakraborty, MD | Targeted inhibition of the MAPK pathway in combination with immune checkpoint inhibitors restores immune dysfunction ex vivo and reduces disease burden in a mouse model of Langerhans cell histiocytosis | Nein Videos available |
| Simonetta Gerevini, MD | CNS imaging in ECD Workshop | Nein Videos available |
| Claudio Doglioni, MD | State of the Art of ECD Pathology Workshop | Nein Videos available |
| Antonio Esposito, MD | Cardiac Imaging in ECD Workshop | Nein Videos available |
| Kazuhiro Toyama, MD | Prognostic factors of Erdheim–Chester Disease: A nationwide survey in Japan | Nein Videos available |
| Dr. med. Eli L. Diamond | Phase 2 Trial of Cobimetinib for Adults with Histiocytosis: Results in BRAFV600-wildtype and BRAFV600E-mutated patients | Nein Videos available |
| Roei Mazor, MD | Diagnostic & Therapeutic Challenges of Mixed Histiocytosis in the Era of Precision Medicine | Nein Videos available |
| Kathy Brewer and Lorenzo Dagna, MD | Closing | Nein Videos available |
Photographs
Reception
